The effect of bowel resection on survival in advanced epithelial ovarian cancer

被引:63
作者
Jaeger, W
Ackermann, S
Kessler, H
Katalinic, A
Lang, N
机构
[1] Univ Erlangen Nurnberg, Frauenklin, Dept Obstet & Gynecol, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Surg, D-91054 Erlangen, Germany
[3] Univ Luebeck, Inst Canc Epidemiol, Lubeck, Germany
关键词
ovarian cancer; surgical treatment; bowel metastases; bowel resection;
D O I
10.1006/gyno.2001.6375
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. FIGO stage III ovarian cancer is further categorized according to the size of tumor, but not according to the organs affected. In this study we evaluated the outcome of patients with and without macroscopic bowel involvement in stage III ovarian cancer. Methods. This retrospective study analyzed the outcome of 194 ovarian cancer patients with FIGO III with and without bowel involvement who were operated on in our institution between 1985 and 1994. Results. The study demonstrated that maximum tumor reduction without remaining macroscopic cancer offered the best overall survival times in FIGO III ovarian cancer patients. However, whenever the bowel was involved, even maximum bowel resections did not prolong survival compared to patients with remaining tumor after surgery. Conclusions. This retrospective study demonstrated that bowel involvement in ovarian cancer had a bad prognosis and that survival in these patients could not substantially be prolonged when the affected parts of bowel were resected. To further substantiate these findings, future studies on advanced ovarian cancer should differentiate between patients with and without bowel involvement. (C) 2001 Academic Press.
引用
收藏
页码:286 / 291
页数:6
相关论文
共 50 条
  • [31] Metastasis patterns of the spleen and association with survival outcomes in advanced ovarian–tubal–peritoneal epithelial cancer
    Yasin Durmuş
    Esra İşçi Bostancı
    Ayşe Sinem Duru Çöteli
    Fulya Kayıkçıoğlu
    Nurettin Boran
    Archives of Gynecology and Obstetrics, 2019, 300 : 1367 - 1375
  • [32] Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer
    Bartl, Thomas
    Schwameis, Richard
    Stift, Anton
    Bachleitner-Hofmann, Thomas
    Reinthaller, Alexander
    Grimm, Christoph
    Polterauer, Stephan
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (09) : 1664 - 1671
  • [33] Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis
    Ghirardi, V
    Moruzzi, M. C.
    Bizzarri, N.
    Vargiu, V.
    D'Indinosante, M.
    Garganese, G.
    Pasciuto, T.
    Loverro, M.
    Scambia, G.
    Fagotti, A.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (01) : 209 - 213
  • [34] Extrapelvic bowel resection and anastomosis in cytoreductive surgery for ovarian cancer
    Son, Joo-Hyuk
    Chang, Suk-Joon
    GLAND SURGERY, 2021, 10 (03) : 1207 - 1211
  • [35] Impact of beta blockers on epithelial ovarian cancer survival
    Diaz, Elena S.
    Karlan, Beth Y.
    Li, Andrew J.
    GYNECOLOGIC ONCOLOGY, 2012, 127 (02) : 375 - 378
  • [36] Impact of statin therapy on survival in epithelial ovarian cancer
    Elmore, R. Geoffrey
    Ioffe, Yevgeniya
    Scoles, Daniel R.
    Karlan, Beth Y.
    Li, Andrew J.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (01) : 102 - 105
  • [37] Advanced epithelial ovarian cancer:: 1998 consensus statements
    Berek, JS
    Bertelsen, K
    du Bois, A
    Brady, MF
    Carmichael, J
    Eisenhauer, EA
    Gore, M
    Grenman, S
    Hamilton, TC
    Hansen, SW
    Harper, PG
    Horvath, G
    Kaye, SB
    Lück, HJ
    Lund, B
    McGuire, WP
    Neijt, JP
    Ozols, RF
    Parmar, MKB
    Piccart-Gebhart, MJ
    van Rijswijk, R
    Rosenberg, P
    Rustin, GJS
    Sessa, C
    Thigpen, JT
    Tropé, C
    Tuxen, MK
    Vergote, I
    Vermorken, JB
    Willemse, PHB
    ANNALS OF ONCOLOGY, 1999, 10 : 87 - 92
  • [38] The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer
    Hakan Karagol
    Pinar Saip
    Kazim Uygun
    Murat Caloglu
    Yesim Eralp
    Faruk Tas
    Adnan Aydiner
    Erkan Topuz
    Medical Oncology, 2007, 24 : 39 - 43
  • [39] Optimal cytoreduction for advanced epithelial ovarian cancer: A commentary
    Eisenkop, Scott M.
    Spirtos, Nick M.
    Lin, Wei-Chien Michael
    GYNECOLOGIC ONCOLOGY, 2006, 103 (01) : 329 - 335
  • [40] The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer
    Karagol, Hakan
    Saip, Pinar
    Uygun, Kazim
    Caloglu, Murat
    Eralp, Yesim
    Tas, Faruk
    Aydiner, Adnan
    Topuz, Erkan
    MEDICAL ONCOLOGY, 2007, 24 (01) : 39 - 43